{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:51:00Z","timestamp":1791258660792,"version":"4.1.0"},"reference-count":49,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,1]]},"abstract":"<jats:p>Caveolae are the major cellular membrane structure through which extracellular mediators transmit information to intracellular signaling pathways. In vascular tissue (but not ventricular myocardium), caveolin-1 (cav-1) is the main component of caveolae; cav-1 modulates enzymes and receptors, such as the endothelial nitric oxide synthase and the angiotensin II (AngII) type 1 receptor. Evidence suggests that AngII and aldosterone (ALDO) are important mediators of ventricular injury. We have described a model of biventricular damage in rodents that relies on treatment with N-\u03c9-nitro-l-arginine methyl ester (L-NAME (nitric oxide synthase inhibitor)) and AngII. This damage initiated at the vascular level and was observed only in the presence of ALDO and an activated mineralocorticoid receptor (MR). We hypothesize that cav-1 modulates the adverse cardiac effects mediated by ALDO in this animal model. To test this hypothesis, we assessed the ventricular damage and measures of inflammation, in wild-type (WT) and cav-1 knockout (KO) mice randomized to either placebo or L-NAME\/AngII treatment. Despite displaying cardiac hypertrophy at baseline and higher blood pressure responses to L-NAME\/AngII, cav-1 KO mice displayed, as compared with WT, decreased treatment-induced biventricular damage as well as decreased transcript levels of the proinflammatory marker plasminogen activator inhibitor-1. Additionally, L-NAME\/AngII induced an increase in cardiac MR levels in WT but not cav-1-ablated mice. Moreover and despite similar circulating ALDO levels in both genotypes, the myocardial damage (as determined histologically and by plasminogen activator inhibitor-1 mRNA levels) was less sensitive to ALDO levels in cav-1 KO vs. WT mice, consistent with decreased MR signaling in the cav-1 KO. Thus, we conclude that the L-NAME\/AngII-induced biventricular damage is mediated by a mechanism partially dependent on cav-1 and signaling via MR\/ALDO.<\/jats:p>","DOI":"10.1210\/en.2009-0514","type":"journal-article","created":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T20:50:27Z","timestamp":1264193427000},"page":"1236-1246","source":"Crossref","is-referenced-by-count":49,"title":["Caveolin-1 Ablation Reduces the Adverse Cardiovascular Effects of N-\u03c9-Nitro-l-Arginine Methyl Ester and Angiotensin II"],"prefix":"10.1210","volume":"151","author":[{"given":"Luminita H.","family":"Pojoga","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Romero","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tham M.","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Loutraris","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ricchiuti","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Coutinho","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lapointe","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Stone","sequence":"first","affiliation":[{"name":"Department of Pathology (J.R.S.), Massachusetts General Hospital\/Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail K.","family":"Adler","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Hypertension (L.H.P., J.R.R., T.M.Y., P.L., V.R., P.C., C.G., N.L., G.K.A., G.H.W.), Brigham and Women\u2019s Hospital\/Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,1,22]]},"reference":[{"key":"2020071612293765800_R1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2174\/138161207780831202","article-title":"Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular disease.","volume":"13","author":"Frank","year":"2007","journal-title":"Curr Pharm Des"},{"key":"2020071612293765800_R2","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1074\/jbc.272.10.6525","article-title":"Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins.","volume":"272","author":"Couet","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071612293765800_R3","doi-asserted-by":"crossref","first-page":"25437","DOI":"10.1074\/jbc.272.41.25437","article-title":"Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo.","volume":"272","author":"Garci\u0301a-Carden\u0303a","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071612293765800_R4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.RES.88.2.229","article-title":"Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold.","volume":"88","author":"Li","year":"2001","journal-title":"Circ Res"},{"key":"2020071612293765800_R5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/01.HYP.32.3.459","article-title":"Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation.","volume":"32","author":"Ishizaka","year":"1998","journal-title":"Hypertension"},{"key":"2020071612293765800_R6","doi-asserted-by":"crossref","first-page":"23738","DOI":"10.1074\/jbc.M212892200","article-title":"Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane.","volume":"278","author":"Wyse","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071612293765800_R7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/01.HYP.0000242907.70697.5d","article-title":"Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle.","volume":"48","author":"Ushio-Fukai","year":"2006","journal-title":"Hypertension"},{"key":"2020071612293765800_R8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/mol.104.010637","article-title":"Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors.","volume":"68","author":"Olivares-Reyes","year":"2005","journal-title":"Mol Pharmacol"},{"key":"2020071612293765800_R9","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1210\/en.2002-220679","article-title":"A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling.","volume":"143","author":"Leclerc","year":"2002","journal-title":"Endocrinology"},{"key":"2020071612293765800_R10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1124\/mi.3.8.445","article-title":"The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.","volume":"3","author":"Hnasko","year":"2003","journal-title":"Mol Interv"},{"key":"2020071612293765800_R11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00046.2003","article-title":"Role of caveolae and caveolins in health and disease.","volume":"84","author":"Cohen","year":"2004","journal-title":"Physiol Rev"},{"key":"2020071612293765800_R12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1126\/science.1062688","article-title":"Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.","volume":"293","author":"Drab","year":"2001","journal-title":"Science"},{"key":"2020071612293765800_R13","doi-asserted-by":"crossref","first-page":"38121","DOI":"10.1074\/jbc.M105408200","article-title":"Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.","volume":"276","author":"Razani","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612293765800_R14","doi-asserted-by":"crossref","first-page":"H1258","DOI":"10.1152\/ajpheart.01014.2007","article-title":"Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1 deficient mice","volume":"294","author":"Pojoga","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071612293765800_R15","doi-asserted-by":"crossref","first-page":"R1222","DOI":"10.1152\/ajpregu.00092.2007","article-title":"Arterial remodeling and plasma volume expansion in caveolin-1-deficient mice","volume":"293","author":"Albinsson","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2020071612293765800_R16","doi-asserted-by":"crossref","first-page":"11375","DOI":"10.1073\/pnas.172360799","article-title":"Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.","volume":"99","author":"Zhao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612293765800_R17","doi-asserted-by":"crossref","first-page":"C457","DOI":"10.1152\/ajpcell.00380.2002","article-title":"Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42\/44 MAP kinase in cardiac fibroblasts","volume":"284","author":"Cohen","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"2020071612293765800_R18","doi-asserted-by":"crossref","first-page":"15124","DOI":"10.1021\/bi0356348","article-title":"Caveolin-1 null (\u2212\/\u2212) mice show dramatic reductions in life span","volume":"42","author":"Park","year":"2003","journal-title":"Biochemistry"},{"key":"2020071612293765800_R19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbrc.2005.12.058","article-title":"Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure.","volume":"340","author":"Wunderlich","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612293765800_R20","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1084\/jem.20062340","article-title":"Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice.","volume":"204","author":"Murata","year":"2007","journal-title":"J Exp Med"},{"key":"2020071612293765800_R21","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612293765800_R22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hyp.39.2.614","article-title":"Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.","volume":"39","author":"Martinez","year":"2002","journal-title":"Hypertension"},{"key":"2020071612293765800_R23","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","article-title":"Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-nitro-l-arginine methyl ester-induced myocardial injury.","volume":"108","author":"Oestreicher","year":"2003","journal-title":"Circulation"},{"key":"2020071612293765800_R24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardiores.2007.03.027","article-title":"S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes.","volume":"75","author":"Schneider","year":"2007","journal-title":"Cardiovasc Res"},{"key":"2020071612293765800_R25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MNH.0b013e328040bfbd","article-title":"Vascular signaling through cholesterol-rich domains: implications in hypertension.","volume":"16","author":"Callera","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2020071612293765800_R26","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"2020071612293765800_R27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1074\/jbc.272.2.1276","article-title":"Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms.","volume":"272","author":"Venema","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071612293765800_R28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5551\/jat.12.138","article-title":"A simple method of isolating mouse aortic endothelial cells.","volume":"12","author":"Kobayashi","year":"2005","journal-title":"J Atheroscler Thromb"},{"key":"2020071612293765800_R29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1290\/1543-706X(2003)039<0402:ASMFTI>2.0.CO;2","article-title":"A stepwise method for the isolation of endothelial cells and smooth muscle cells from individual canine coronary arteries.","volume":"39","author":"Dame","year":"2003","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2020071612293765800_R30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0895-7061(95)00259-6","article-title":"Relation of stress testing and ambulatory blood pressure to hypertensive cardiac damage.","volume":"9","author":"Cardillo","year":"1996","journal-title":"Am J Hypertens"},{"key":"2020071612293765800_R31","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1046\/j.1523-1755.1998.06751.x","article-title":"Sodium, angiotensin II, blood pressure, and cardiac hypertrophy","volume":"67","author":"Morgan","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"2020071612293765800_R32","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace.","volume":"113","author":"Fo\u0308rstermann","year":"2006","journal-title":"Circulation"},{"key":"2020071612293765800_R33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.HYP.38.3.404","article-title":"Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.","volume":"38","author":"Sanada","year":"2001","journal-title":"Hypertension"},{"key":"2020071612293765800_R34","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000015603.84788.47","article-title":"Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway.","volume":"105","author":"Kalra","year":"2002","journal-title":"Circulation"},{"key":"2020071612293765800_R35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/jpet.104.070151","article-title":"Role of protein kinase C\u0394 in endothelin-induced type I collagen expression in cardiac myofibroblasts isolated from the site of myocardial infarction.","volume":"311","author":"Chintalgattu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071612293765800_R36","doi-asserted-by":"crossref","first-page":"H2403","DOI":"10.1152\/ajpheart.00288.2007","article-title":"Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases","volume":"293","author":"Zhang","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071612293765800_R37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FJC.0b013e318181fadd","article-title":"Phospholipase C\/protein kinase C pathway mediates angiotensin II-dependent apoptosis in neonatal rat cardiac fibroblasts expressing AT1 receptor.","volume":"52","author":"Vivar","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"2020071612293765800_R38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/HYPERTENSIONAHA.107.098459","article-title":"Angiotensin II-induced extracellular signal-regulated kinase 1\/2 activation is mediated by protein kinase C\u0394 and intracellular calcium in adult rat cardiac fibroblasts.","volume":"51","author":"Olson","year":"2008","journal-title":"Hypertension"},{"key":"2020071612293765800_R39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(98)00945-4","article-title":"Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes.","volume":"434","author":"Li","year":"1998","journal-title":"FEBS Lett"},{"key":"2020071612293765800_R40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2008.10.068","article-title":"Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice.","volume":"377","author":"Wunderlich","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612293765800_R41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0163-7258(99)00072-8","article-title":"Paracrine and autocrine effects of nitric oxide on myocardial function.","volume":"86","author":"Shah","year":"2000","journal-title":"Pharmacol Ther"},{"key":"2020071612293765800_R42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/HYPERTENSIONAHA.107.092049","article-title":"Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency.","volume":"50","author":"Yamashita","year":"2007","journal-title":"Hypertension"},{"key":"2020071612293765800_R43","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.","volume":"97","author":"Paradis","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612293765800_R44","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1074\/jbc.271.25.15160","article-title":"Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins.","volume":"271","author":"Song","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612293765800_R45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/bj3590203","article-title":"Ligand-independent activation of oestrogen receptor \u03b1 by caveolin-1.","volume":"359","author":"Schlegel","year":"2001","journal-title":"Biochem J"},{"key":"2020071612293765800_R46","doi-asserted-by":"crossref","first-page":"13442","DOI":"10.1074\/jbc.M006598200","article-title":"Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation.","volume":"276","author":"Lu","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612293765800_R47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/bbrc.1999.1348","article-title":"Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor \u03b1 localized in caveolae.","volume":"263","author":"Kim","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612293765800_R48","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1074\/jbc.M708751200","article-title":"EF domains are sufficient for nongenomic mineralocorticoid receptor actions.","volume":"283","author":"Grossmann","year":"2008","journal-title":"J Biol Chem"},{"key":"2020071612293765800_R49","doi-asserted-by":"crossref","first-page":"33541","DOI":"10.1074\/jbc.C200309200","article-title":"Endogenously expressed epithelial sodium channel is present in lipid rafts in A6 cells.","volume":"277","author":"Hill","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/3\/1236\/9011540\/endo1236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/3\/1236\/9011540\/endo1236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T14:12:37Z","timestamp":1634739157000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/151\/3\/1236\/2456616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,22]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2009-0514","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,22]]}}}